In the News
High Intensity Focused Ultrasound: A novel and non-invasive approach to target tumors.
In 2014, FUSMobile co-founders Arik Hananel, MD, and Ron Aginsky, LLB, MBA, identified a need for a compact, mobile, and user-friendly focused ultrasound device. They set out to create such a product, and less than five years later, the company has completed a pilot clinical trial using their Neurolyser device.
FUSMobile’s Neurolyser device uses image-guided high-intensity focused ultrasound ablation to alleviate chronic pain noninvasively and at reduced cost.
